ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P67: LONG-TERM MANAGEMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB AND CONCOMITANT TOPICAL CORTICOSTEROIDS: A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL (CHRONOS)
Internal Medicine Journal
◽
10.1111/imj.67_13578
◽
2017
◽
Vol 47
◽
pp. 25-25
◽
Cited By ~ 5
Author(s):
A Blauvelt
◽
M Gooderham
◽
P Foley
◽
Griffiths CEM
◽
JC Cather
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
◽
Term Management
Download Full-text
Related Documents
Cited By
References
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
The Lancet
◽
10.1016/s0140-6736(17)31191-1
◽
2017
◽
Vol 389
(10086)
◽
pp. 2287-2303
◽
Cited By ~ 364
Author(s):
Andrew Blauvelt
◽
Marjolein de Bruin-Weller
◽
Melinda Gooderham
◽
Jennifer C Cather
◽
Jamie Weisman
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
◽
Double Blinded
◽
Term Management
Download Full-text
Faculty Opinions recommendation of Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727591680.793534051
◽
2017
◽
Author(s):
Hidehisa Saeki
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
◽
Double Blinded
◽
Term Management
Download Full-text
Faculty Opinions recommendation of Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727591680.793555533
◽
2019
◽
Author(s):
Carsten Flohr
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
◽
Double Blinded
◽
Term Management
Download Full-text
Long‐term management of moderate‐to‐severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal
British Journal of Dermatology
◽
10.1111/bjd.16520
◽
2018
◽
Vol 178
(4)
◽
Author(s):
J. Thomson
◽
A.G.H. Wernham
◽
H.C. Williams
Keyword(s):
Atopic Dermatitis
◽
Critical Appraisal
◽
Severe Atopic Dermatitis
◽
Topical Corticosteroids
◽
Term Management
Download Full-text
Long‐term management of moderate‐to‐severe atopic dermatitis with dupilumab and concomitant topical corticosteroids ( LIBERTY AD CHRONOS ): a critical appraisal
British Journal of Dermatology
◽
10.1111/bjd.16317
◽
2018
◽
Vol 178
(4)
◽
pp. 897-902
◽
Cited By ~ 8
Author(s):
J. Thomson
◽
A.G.H. Wernham
◽
H.C. Williams
Keyword(s):
Atopic Dermatitis
◽
Critical Appraisal
◽
Severe Atopic Dermatitis
◽
Topical Corticosteroids
◽
Term Management
Download Full-text
Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.99
◽
2020
◽
Vol 4
(6)
◽
pp. s99
Author(s):
Jonathan Silverberg
◽
Andrew Pink
◽
Christina Olsen
◽
Stephan Weidinger
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
Abstract not available.
Download Full-text
27697 Long-term efficacy, safety, and adherence to tralokinumab treatment in moderate-to-severe atopic dermatitis for up to 3 years: Interim readout of ECZTEND, a phase 3, long-term extension trial
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2021.06.650
◽
2021
◽
Vol 85
(3)
◽
pp. AB159
Author(s):
Andrew Blauvelt
◽
Jean-Philippe Lacour
◽
Darryl Toth
◽
Vivian Laquer
◽
Stefan Beissert
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Term Efficacy
◽
Extension Trial
Download Full-text
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)
SSRN Electronic Journal
◽
10.2139/ssrn.3748383
◽
2020
◽
Author(s):
Kristian Reich
◽
Henrique D. Teixeira
◽
Marjolein de Bruin-Weller
◽
Thomas Bieber
◽
Weily Soong
◽
...
Keyword(s):
Atopic Dermatitis
◽
Controlled Study
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Pivotal Phase
◽
Double Blind
◽
Safety And Efficacy
◽
Double Blind Placebo
◽
Topical Corticosteroids
◽
Adolescents And Adults
Download Full-text
Corrigendum to "Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.2020;82:823-31
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2021.07.010
◽
2021
◽
Keyword(s):
Atopic Dermatitis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Controlled Study
◽
Severe Atopic Dermatitis
◽
Open Label
◽
Phase 3
◽
Double Blind
◽
Janus Kinase Inhibitor
Download Full-text
28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2021.06.697
◽
2021
◽
Vol 85
(3)
◽
pp. AB171
Author(s):
Andrew Blauvelt
◽
Michael R. Ardern-Jones
◽
Thomas Bieber
◽
Chih-ho Hong
◽
Chia-Yu Chu
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close